Cardiac Biomarkers Market Size, Share & Trends Analysis Report By Type (Troponin, CK-MB, Myoglobin, BNP And NT-proBNP), By Application (Acute Coronary Syndrome, Myocardial Infarction), By End-use, By Region, And Segment Forecasts, 2023

The global cardiac biomarkers market size is expected to reach USD 47.88 billion by 2030, expanding at a CAGR of 14.6% from 2023 to 2030. The increasing prevalence of acute coronary syndrome (ACS), along with advancements in biomarker technologies, is expected to propel market growth. The rising awareness regarding early diagnosis and prognosis of cardiac diseases is expected to further drive the market.

According to the NCBI, in 2021, in the U.S., over 15.5 million people were affected by coronary heart disease. Chest pain is one of the most common reasons for emergency department visits. Heart disease is one of the major causes of death in the U.S. and it is estimated that a person has a heart attack every 41 seconds. Cardiac biomarkers play a significant role in ACS diagnosis and facilitate faster treatment decision-making, thereby making them crucial.

The improving adoption of biomarkers in risk stratification and diagnosis of the acute coronary syndrome is impelling the demand. An unhealthy lifestyle is driving the prevalence of acute coronary syndrome and myocardial infarction. The increasing adoption of PoC diagnostics is driving segment innovation, making use of cardiac markers easier. The paradigm shift in the adoption of cardiac biomarkers in hospitals and PoC settings can be attributed to the recent developments in assays pertaining to the sensitivity of cardiac troponin I and cardiac troponin T.

Moreover, the rise in the availability of novel assays is one of the major drivers anticipated to boost market growth in the upcoming years. This is driving the movement of new players in the segment. For instance, in May 2021, Shenzhen Mindray Bio-Medical Electronics announced its plan to acquire HyTest, which is involved in cardiac biomarkers sales, for USD 661 million. In-house production of raw materials is becoming an area of prime focus for companies to ensure a steady flow of raw materials.

Cardiac Biomarkers Market Report Highlights

By type, the troponin segment held the largest revenue share in 2022 owing to its high usage in cardiovascular diseases diagnosis
Based on application, the acute coronary syndrome segment is expected to grow at a lucrative rate during the forecast period due to the increasing prevalence of coronary diseases and expanding applications of these biomarkers in the diagnosis and treatment of diseases
North America dominated the global market in 2022 owing to the presence of a developed healthcare system that facilitates easier adoption of cardiac biomarkers as a tool for diagnosis and prognosis
Asia Pacific is expected to grow at a significant rate during the forecast period. This can be attributed to the presence of a wide target population and leading companies that are making R&D investments in countries such as China and Japan

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
1.1.1. Type
1.1.2. Application
1.1.3. End use
1.1.4. Regional scope
1.1.5. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Type outlook
2.2.2. Application outlook
2.2.3. End use outlook
2.2.4. Regional outlook
2.3. Competitive Insights

Chapter 3. Cardiac Biomarkers Market Variables, Trends & Scope

3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.4. Cardiac Biomarkers Market Analysis Tools
3.4.1. Industry Analysis - Porter’s
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic landscape

Chapter 4. Cardiac Biomarkers: Type Estimates & Trend Analysis

4.1. Cardiac Biomarkers Market: Key Takeaways
4.2. Cardiac Biomarkers Market: Movement & Market Share Analysis, 2022 & 2030
4.3. Troponin
4.3.1. Troponin market estimates and forecasts, 2018 to 2030 (USD Million)
4.4. CK-MB
4.4.1. CK-MB market estimates and forecasts, 2018 to 2030 (USD Million)
4.5. Myoglobin
4.5.1. Myoglobin market estimates and forecasts, 2018 to 2030 (USD Million)
4.6. BNP and NT-proBNP
4.6.1. BNP and NT-proBNP market estimates and forecasts, 2018 to 2030 (USD Million)
4.7. Others
4.7.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Cardiac Biomarkers: Application Estimates & Trend Analysis

5.1. Cardiac Biomarkers Market: Key Takeaways
5.2. Cardiac Biomarkers Market: Movement & Market Share Analysis, 2022 & 2030
5.3. Acute Coronary Syndrome
5.3.1. Acute coronary syndrome market estimates and forecasts, 2018 to 2030 (USD Million)
5.4. Myocardial Infarction
5.4.1. Myocardial infarction market estimates and forecasts, 2018 to 2030 (USD Million)
5.5. Congestive Heart Failure
5.5.1. Congestive heart failure market estimates and forecasts, 2018 to 2030 (USD Million)
5.6. Others
5.6.1. Other market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Cardiac Biomarkers: End Use Estimates & Trend Analysis

6.1. Cardiac Biomarkers Market: Key Takeaways
6.2. Cardiac Biomarkers Market: Movement & Market Share Analysis, 2022 & 2030
6.3. Laboratory Testing
6.3.1. Laboratory testing market estimates and forecasts, 2018 to 2030 (USD Million)
6.4. Point of Care Testing
6.4.1. Point of care testing market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Cardiac Biomarkers Market: Regional Estimates & Trend Analysis

7.1. Regional Outlook
7.2. Cardiac Biomarkers Market by Region: Key Takeaways
7.3. North America
7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.3.2. U.S.
7.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.3.3. Canada
7.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4. Europe
7.4.1. UK
7.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.2. Germany
7.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.3. France
7.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.4. Italy
7.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.5. Spain
7.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.6. Denmark
7.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.7. Sweden
7.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.8. Norway
7.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5. Asia Pacific
7.5.1. Japan
7.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5.2. China
7.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5.3. India
7.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5.4. Australia
7.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5.5. Thailand
7.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5.6. South Korea
7.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.6. Latin America
7.6.1. Brazil
7.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.6.2. Mexico
7.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.6.3. Argentina
7.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.7. MEA
7.7.1. South Africa
7.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.7.2. Saudi Arabia
7.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.7.3. UAE
7.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.7.4. Kuwait
7.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 8. Competitive Landscape

8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.2.1. Abbott
8.2.1.1. Company overview
8.2.1.2. Financial performance
8.2.1.3. Product benchmarking
8.2.1.4. Strategic initiatives
8.2.2. Quidel Corporation
8.2.2.1. Company overview
8.2.2.2. Financial performance
8.2.2.3. Product benchmarking
8.2.2.4. Strategic initiatives
8.2.3. Siemens Healthineers GmbH
8.2.3.1. Company overview
8.2.3.2. Financial performance
8.2.3.3. Product benchmarking
8.2.3.4. Strategic initiatives
8.2.4. F. Hoffmann-La Roche Ltd.
8.2.4.1. Company overview
8.2.4.2. Financial performance
8.2.4.3. Product benchmarking
8.2.4.4. Strategic initiatives
8.2.5. Danaher
8.2.5.1. Company overview
8.2.5.2. Financial performance
8.2.5.3. Product benchmarking
8.2.5.4. Strategic initiatives
8.2.6. BIOMÉRIEUX
8.2.6.1. Company overview
8.2.6.2. Financial performance
8.2.6.3. Product benchmarking
8.2.6.4. Strategic initiatives
8.2.7. Bio-Rad Laboratories, Inc.
8.2.7.1. Company overview
8.2.7.2. Financial performance
8.2.7.3. Product benchmarking
8.2.7.4. Strategic initiatives
8.2.8. Randox Laboratories Ltd.
8.2.8.1. Company overview
8.2.8.2. Financial performance
8.2.8.3. Product benchmarking
8.2.8.4. Strategic initiatives
8.2.9. Creative Diagnostics
8.2.9.1. Company overview
8.2.9.2. Financial performance
8.2.9.3. Product benchmarking
8.2.9.4. Strategic initiatives
8.2.10. Life Diagnostics
8.2.10.1. Company overview
8.2.10.2. Financial performance
8.2.10.3. Product benchmarking
8.2.10.4. Strategic initiatives

List of Tables

Table 1 List of Abbreviation
Table 2 North America cardiac biomarkers market, by type, 2018-2030 (USD Million)
Table 3 North America cardiac biomarkers market, by application, 2018-2030 (USD Million)
Table 4 North America cardiac biomarkers market, by end use, 2018-2030 (USD Million)
Table 5 North America cardiac biomarkers market, by region, 2018-2030 (USD Million)
Table 6 U.S. cardiac biomarkers market, by type, 2018-2030 (USD Million)
Table 7 U.S. cardiac biomarkers market, by application, 2018-2030 (USD Million)
Table 8 U.S. cardiac biomarkers market, by end use, 2018-2030 (USD Million)
Table 9 Canada cardiac biomarkers market, by type, 2018-2030 (USD Million)
Table 10 Canada cardiac biomarkers market, by application, 2018-2030 (USD Million)
Table 11 Canada cardiac biomarkers market, by end use, 2018-2030 (USD Million)
Table 12 Europe cardiac biomarkers market, by type, 2018-2030 (USD Million)
Table 13 Europe cardiac biomarkers market, by application, 2018-2030 (USD Million)
Table 14 Europe cardiac biomarkers market, by end use, 2018-2030 (USD Million)
Table 15 Europe cardiac biomarkers market, by region, 2018-2030 (USD Million)
Table 16 Germany cardiac biomarkers market, by type, 2018-2030 (USD Million)
Table 17 Germany cardiac biomarkers market, by application, 2018-2030 (USD Million)
Table 18 Germany cardiac biomarkers market, by end use, 2018-2030 (USD Million)
Table 19 UK cardiac biomarkers market, by type, 2018-2030 (USD Million)
Table 20 UK cardiac biomarkers market, by application, 2018-2030 (USD Million)
Table 21 UK cardiac biomarkers market, by end use, 2018-2030 (USD Million)
Table 22 France cardiac biomarkers market, by type, 2018-2030 (USD Million)
Table 23 France cardiac biomarkers market, by application, 2018-2030 (USD Million)
Table 24 France cardiac biomarkers market, by end use, 2018-2030 (USD Million)
Table 25 Italy cardiac biomarkers market, by type, 2018-2030 (USD Million)
Table 26 Italy cardiac biomarkers market, by application, 2018-2030 (USD Million)
Table 27 Italy cardiac biomarkers market, by end use, 2018-2030 (USD Million)
Table 28 Spain cardiac biomarkers market, by type, 2018-2030 (USD Million)
Table 29 Spain cardiac biomarkers market, by application, 2018-2030 (USD Million)
Table 30 Spain cardiac biomarkers market, by end use, 2018-2030 (USD Million)
Table 31 Denmark cardiac biomarkers market, by type, 2018-2030 (USD Million)
Table 32 Denmark cardiac biomarkers market, by application, 2018-2030 (USD Million)
Table 33 Denmark cardiac biomarkers market, by end use, 2018-2030 (USD Million)
Table 34 Sweden cardiac biomarkers market, by type, 2018-2030 (USD Million)
Table 35 Sweden cardiac biomarkers market, by application, 2018-2030 (USD Million)
Table 36 Sweden cardiac biomarkers market, by end use, 2018-2030 (USD Million)
Table 37 Norway cardiac biomarkers market, by type, 2018-2030 (USD Million)
Table 38 Norway cardiac biomarkers market, by application, 2018-2030 (USD Million)
Table 39 Norway cardiac biomarkers market, by end use, 2018-2030 (USD Million)
Table 40 Asia Pacific cardiac biomarkers market, by type, 2018-2030 (USD Million)
Table 41 Asia Pacific cardiac biomarkers market, by application, 2018-2030 (USD Million)
Table 42 Asia Pacific cardiac biomarkers market, by end use, 2018-2030 (USD Million)
Table 43 Asia Pacific cardiac biomarkers market, by region, 2018-2030 (USD Million)
Table 44 Japan cardiac biomarkers market, by type, 2018-2030 (USD Million)
Table 45 Japan cardiac biomarkers market, by application, 2018-2030 (USD Million)
Table 46 Japan cardiac biomarkers market, by end use, 2018-2030 (USD Million)
Table 47 China cardiac biomarkers market, by type, 2018-2030 (USD Million)
Table 48 China cardiac biomarkers market, by application, 2018-2030 (USD Million)
Table 49 China cardiac biomarkers market, by end use, 2018-2030 (USD Million)
Table 50 India cardiac biomarkers market, by type, 2018-2030 (USD Million)
Table 51 India cardiac biomarkers market, by application, 2018-2030 (USD Million)
Table 52 India cardiac biomarkers market, by end use, 2018-2030 (USD Million)
Table 53 Australia cardiac biomarkers market, by type, 2018-2030 (USD Million)
Table 54 Australia cardiac biomarkers market, by application, 2018-2030 (USD Million)
Table 55 Australia cardiac biomarkers market, by end use, 2018-2030 (USD Million)
Table 56 Thailand cardiac biomarkers market, by type, 2018-2030 (USD Million)
Table 57 Thailand cardiac biomarkers market, by application, 2018-2030 (USD Million)
Table 58 Thailand cardiac biomarkers market, by end use, 2018-2030 (USD Million)
Table 59 South Korea cardiac biomarkers market, by type, 2018-2030 (USD Million)
Table 60 South Korea cardiac biomarkers market, by application, 2018-2030 (USD Million)
Table 61 South Korea cardiac biomarkers market, by end use, 2018-2030 (USD Million)
Table 62 Latin America cardiac biomarkers market, by type, 2018-2030 (USD Million)
Table 63 Latin America cardiac biomarkers market, by application, 2018-2030 (USD Million)
Table 64 Latin America cardiac biomarkers market, by end use, 2018-2030 (USD Million)
Table 65 Latin America cardiac biomarkers market, by region, 2018-2030 (USD Million)
Table 66 Brazil cardiac biomarkers market, by type, 2018-2030 (USD Million)
Table 67 Brazil cardiac biomarkers market, by application, 2018-2030 (USD Million)
Table 68 Brazil cardiac biomarkers market, by end use, 2018-2030 (USD Million)
Table 69 Mexico cardiac biomarkers market, by type, 2018-2030 (USD Million)
Table 70 Mexico cardiac biomarkers market, by application, 2018-2030 (USD Million)
Table 71 Mexico cardiac biomarkers market, by end use, 2018-2030 (USD Million)
Table 72 Argentina cardiac biomarkers market, by type, 2018-2030 (USD Million)
Table 73 Argentina cardiac biomarkers market, by application, 2018-2030 (USD Million)
Table 74 Argentina cardiac biomarkers market, by end use, 2018-2030 (USD Million)
Table 75 Middle East and Africa cardiac biomarkers market, by type, 2018-2030 (USD Million)
Table 76 Middle East and Africa cardiac biomarkers market, by application, 2018-2030 (USD Million)
Table 77 Middle East and Africa cardiac biomarkers market, by end use, 2018-2030 (USD Million)
Table 78 Middle East and Africa cardiac biomarkers market, by region, 2018-2030 (USD Million)
Table 79 South Africa cardiac biomarkers market, by type, 2018-2030 (USD Million)
Table 80 South Africa cardiac biomarkers market, by application, 2018-2030 (USD Million)
Table 81 South Africa cardiac biomarkers market, by end use, 2018-2030 (USD Million)
Table 82 Saudi Arabia cardiac biomarkers market, by type, 2018-2030 (USD Million)
Table 83 Saudi Arabia cardiac biomarkers market, by application, 2018-2030 (USD Million)
Table 84 Saudi Arabia cardiac biomarkers market, by end use, 2018-2030 (USD Million)
Table 85 UAE cardiac biomarkers market, by type, 2018-2030 (USD Million)
Table 86 UAE cardiac biomarkers market, by application, 2018-2030 (USD Million)
Table 87 UAE cardiac biomarkers market, by end use, 2018-2030 (USD Million)
Table 88 Kuwait cardiac biomarkers market, by type, 2018-2030 (USD Million)
Table 89 Kuwait cardiac biomarkers market, by application, 2018-2030 (USD Million)
Table 90 Kuwait cardiac biomarkers market, by end use, 2018-2030 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 QFD modeling for market share assessment
Fig. 6 Market formulation & validation
Fig. 7 Cardiac biomarkers: Market outlook
Fig. 8 Cardiac biomarkers: Competitive insights
Fig. 9 Parent market outlook
Fig. 10 Related/ancillary market outlook
Fig. 11 Penetration and growth prospect mapping
Fig. 12 Cardiac biomarkers market driver impact
Fig. 13 Cardiac biomarkers market restraint impact
Fig. 14 Cardiac biomarkers market strategic initiatives analysis
Fig. 15 Cardiac biomarkers market: Type movement analysis
Fig. 16 Cardiac biomarkers market: Type outlook and key takeaways
Fig. 17 Troponin market estimates and forecasts, 2018-2030 (USD Million)
Fig. 18 CK-MB market estimates and forecasts, 2018-2030 (USD Million)
Fig. 19 Myoglobin market estimates and forecasts, 2018-2030 (USD Million)
Fig. 20 BNP and NT-proBNP market estimates and forecasts, 2018-2030 (USD Million)
Fig. 21 Others market estimates and forecasts, 2018-2030 (USD Million)
Fig. 22 Cardiac biomarkers market: Application movement analysis
Fig. 23 Cardiac biomarkers market: Application outlook and key takeaways
Fig. 24 Acute coronary syndrome market estimates and forecasts, 2018-2030 (USD Million)
Fig. 25 Myocardial infarction market estimates and forecasts, 2018-2030 (USD Million)
Fig. 26 Congestive heart failure market estimates and forecasts, 2018-2030 (USD Million)
Fig. 27 Others market estimates and forecasts, 2018-2030 (USD Million)
Fig. 28 Cardiac biomarkers market: End use movement analysis
Fig. 29 Cardiac biomarkers market: End use outlook and key takeaways
Fig. 30 Laboratory testing market estimates and forecasts, 2018-2030 (USD Million)
Fig. 31 Point of care testing market estimates and forecasts, 2018-2030 (USD Million)
Fig. 32 Pain management market estimates and forecasts, 2018-2030 (USD Million)
Fig. 33 Cancer therapy market estimates and forecasts, 2018-2030 (USD Million)
Fig. 34 Vaccine delivery market estimates and forecasts, 2018-2030 (USD Million)
Fig. 35 Others market estimates and forecasts, 2018-2030 (USD Million)
Fig. 36 Global cardiac biomarkers market: Regional movement analysis
Fig. 37 Global cardiac biomarkers market: Regional outlook and key takeaways
Fig. 38 North America market estimates and forecasts, 2018-2030 (USD Million)
Fig. 39 U.S. market estimates and forecasts, 2018-2030 (USD Million)
Fig. 40 Canada market estimates and forecasts, 2018-2030 (USD Million)
Fig. 41 Europe market estimates and forecasts, 2018-2030 (USD Million)
Fig. 42 UK market estimates and forecasts, 2018-2030 (USD Million)
Fig. 43 Germany market estimates and forecasts, 2018-2030 (USD Million)
Fig. 44 France market estimates and forecasts, 2018-2030 (USD Million)
Fig. 45 Italy market estimates and forecasts, 2018-2030 (USD Million)
Fig. 46 Spain market estimates and forecasts, 2018-2030 (USD Million)
Fig. 47 Denmark market estimates and forecasts, 2018-2030 (USD Million)
Fig. 48 Sweden market estimates and forecasts, 2018-2030 (USD Million)
Fig. 49 Norway market estimates and forecasts, 2018-2030 (USD Million)
Fig. 50 Asia Pacific market estimates and forecasts, 2018-2030 (USD Million)
Fig. 51 Japan market estimates and forecasts, 2018-2030 (USD Million)
Fig. 52 China market estimates and forecasts, 2018-2030 (USD Million)
Fig. 53 India market estimates and forecasts, 2018-2030 (USD Million)
Fig. 54 Australia market estimates and forecasts, 2018-2030 (USD Million)
Fig. 55 Thailand market estimates and forecasts, 2018-2030 (USD Million)
Fig. 56 South Korea market estimates and forecasts, 2018-2030 (USD Million)
Fig. 57 Latin America market estimates and forecasts, 2018-2030 (USD Million)
Fig. 58 Brazil market estimates and forecasts, 2018-2030 (USD Million)
Fig. 59 Mexico market estimates and forecasts, 2018-2030 (USD Million)
Fig. 60 Argentina market estimates and forecasts, 2018-2030 (USD Million)
Fig. 61 Middle East and Africa. market estimates and forecasts, 2018-2030 (USD Million)
Fig. 62 South Africa market estimates and forecasts, 2018-2030 (USD Million)
Fig. 63 Saudi Arabia market estimates and forecasts, 2018-2030 (USD Million)
Fig. 64 UAE market estimates and forecasts, 2018-2030 (USD Million)
Fig. 65 Kuwait market estimates and forecasts, 2018-2030 (USD Million)

Companies Mentioned

Abbott
Quidel Corporation
Siemens Healthineers GmbH
F. Hoffmann-La Roche Ltd.
Danaher
BIOMÉRIEUX
Bio-Rad Laboratories, Inc.
Randox Laboratories Ltd.
Creative Diagnostics
Life Diagnostics

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	120
Published	October 2023
Forecast Period	2022 - 2030
Estimated Market Value ( USD ) in 2022	$ 16.05 Billion
Forecasted Market Value ( USD ) by 2030	$ 47.88 Billion
Compound Annual Growth Rate	14.6%
Regions Covered	Global
No. of Companies Mentioned	10

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€5879EUR$5,950USD£4,893GBP
1 - 5 USER LICENSE PDF	The product is a PDF.	This is a 1-5 user license, allowing up to five users have access to the product.	€6867EUR$6,950USD£5,716GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€8843EUR$8,950USD£7,360GBP

Cardiac Biomarkers Market Size, Share & Trends Analysis Report By Type (Troponin, CK-MB, Myoglobin, BNP And NT-proBNP), By Application (Acute Coronary Syndrome, Myocardial Infarction), By End-use, By Region, And Segment Forecasts, 2023 - 2030

Cardiac Biomarkers Market Report Highlights

Table of Contents

Companies Mentioned

Methodology

Table Information

Cardiac Biomarkers Market Report Highlights

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Cardiac Biomarker Market by Type, Location of Testing, Application - Global Forecast 2025-2030

Cardiac Biomarker Diagnostic Kits Market by Disease, Testing, Product, End-User - Global Forecast 2025-2030

Cardiac Biomarkers Testing Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

Cardiac Biomarkers Market Report by Type, Location of Testing, Application, and Region 2024-2032

Cardiac Biomarkers Market Innovations and Strategic Insights Report - Market Data, Trends, Market Potential, Competitive Analysis and Growth Forecasts (2024 to 2032)